As part of the systemic inflammatory response to a tumour or from the tumour itself, inflammatory mediators are released, including interleukin-1 (IL-1), IL-6, tumour necrosis factor- (TNF-) α, and acute-phase reactants [40]. Here, IL6 is linked to neoplasm.